Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Lassman AB, Pugh SL, Wang TJC, Aldape K, Gan HK, Preusser M, Vogelbaum MA, Sulman EP, Won M, Zhang P, Moazami G, Macsai MS, Gilbert MR, Bain EE, Blot V, Ansell PJ, Samanta S, Kundu MG, Armstrong TS, Wefel JS, Seidel C, de Vos FY, Hsu S, Cardona AF, Lombardi G, Bentsion D, Peterson RA, Gedye C, Bourg V, Wick A, Curran WJ, Mehta MP. Lassman AB, et al. Among authors: bourg v. Neuro Oncol. 2023 Feb 14;25(2):339-350. doi: 10.1093/neuonc/noac173. Neuro Oncol. 2023. PMID: 35849035 Free PMC article. Clinical Trial.
Hypoxemia following generalized convulsive seizures: Risk factors and effect of oxygen therapy.
Rheims S, Alvarez BM, Alexandre V, Curot J, Maillard L, Bartolomei F, Derambure P, Hirsch E, Michel V, Chassoux F, Tourniaire D, Crespel A, Biraben A, Navarro V, Kahane P, De Toffol B, Thomas P, Rosenberg S, Valton L, Bezin L, Ryvlin P; REPO2MSE study group. Rheims S, et al. Neurology. 2019 Jan 15;92(3):e183-e193. doi: 10.1212/WNL.0000000000006777. Epub 2018 Dec 19. Neurology. 2019. PMID: 30568004
Risk factors of postictal generalized EEG suppression in generalized convulsive seizures.
Alexandre V, Mercedes B, Valton L, Maillard L, Bartolomei F, Szurhaj W, Hirsch E, Marchal C, Chassoux F, Petit J, Crespel A, Nica A, Navarro V, Kahane P, De Toffol B, Thomas P, Rosenberg S, Denuelle M, Jonas J, Ryvlin P, Rheims S; REPO2MSE study group. Alexandre V, et al. Neurology. 2015 Nov 3;85(18):1598-603. doi: 10.1212/WNL.0000000000001949. Epub 2015 Sep 2. Neurology. 2015. PMID: 26333799
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.
Darcourt J, Chardin D, Bourg V, Gal J, Schiappa R, Blonski M, Koulibaly PM, Almairac F, Mondot L, Le Jeune F, Collombier L, Kas A, Taillandier L, Verger A. Darcourt J, et al. Among authors: bourg v. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2727-2735. doi: 10.1007/s00259-023-06225-0. Epub 2023 Apr 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 37086272
A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E, Parratte B, Colin C, Denis A, Oudin S, Bérard C, Bernard JC, Bourg V, Deleplanque B, Dulieu I, Evrard P, Filipetti P, Flurin V, Gallien P, Héron-Long B, Hodgkinson I, Husson I, Jaisson-Hot I, Maupas E, Meurin F, Monnier G, Pérennou D, Pialoux B, Quentin V, Moreau MS, Schneider M, Yelnik A, Marque P. Chaléat-Valayer E, et al. Among authors: bourg v. Eur J Paediatr Neurol. 2011 Sep;15(5):439-48. doi: 10.1016/j.ejpn.2010.04.006. Epub 2011 Jul 13. Eur J Paediatr Neurol. 2011. PMID: 21745754
73 results